Arvind Ltd Q1 FY27 Results Analysis: PAT Surges 47%, EBITDA Margin Expands 104 bps

Cofacto Research Updated August 12, 2026 2 min read
Positive

Arvind Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 2,500.96 Cr (+24.65% YoY) and PAT growth of +5.61% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 12, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 2,500.96 Cr (+24.65% YoY)
PAT (Q1)Rs. 57.77 Cr (+5.61% YoY)
EBITDA margin10.32% (+104 bps YoY)
EPS (Q1)Rs. 2.04 (+0.49% YoY)
Market capRs. 15,419.27 Cr
CMPRs. 566.85

Quarter Snapshot

Arvind delivered record Q1 revenue of Rs.2,501 Cr (+25% YoY), with normalized PAT up 47% and EBITDA margin expanding 104 bps. Advanced Materials was the standout, growing 40% and exceeding its 18-20% aspiration. The Dalco-GFT acquisition added a new growth stream, and a Rs.500 Cr post-quarter QIP strengthens the balance sheet. However, input cost pressures compressed textiles margin, and finance costs rose from acquisition debt. Overall, the quarter confirms strong execution and a favourable regulatory tailwind from US tariff relief.

Key Investment Insights

Key Positives

  • Consolidated revenue grew 25% YoY to Rs.2,501 Cr, a record Q1 level.
  • Normalized PAT grew 47% YoY to Rs.80.34 Cr, driven by Advanced Materials and Dalco contribution.
  • Advanced Materials revenue surged 40% YoY, with EBITDA margin expanding 200 bps to 14.9%.
  • EBITDA margin improved 104 bps YoY to 10.3%.
  • Dalco-GFT contributed Rs.157 Cr revenue in first 1.8 months at 15.1% EBITDA margin.
  • Post-quarter Rs.500 Cr QIP strengthens balance sheet and reduces debt.

Risk Factors

  • Textiles segment EBITDA margin compressed 40 bps YoY to 8.0% due to input cost inflation.
  • Finance costs increased 32% YoY to Rs.54.39 Cr from debt taken for Dalco acquisition.
  • Raw material costs (materials consumed + purchases + inventory change) rose to 48.5% of revenue from 47.1% in Q1 FY26.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now